# Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran

> **NCT00886444** · PHASE2,PHASE3 · COMPLETED · sponsor: **Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)** · enrollment: 20 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Ferucarbotran (Resovist)

## Key facts

- **NCT ID:** NCT00886444
- **Lead sponsor:** Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00886444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00886444, "Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00886444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*